Literature DB >> 25456520

Resting state networks in major depressive disorder.

Arpan Dutta1, Shane McKie2, J F William Deakin2.   

Abstract

Resting state functional magnetic resonance imaging (fMRI) examines the spontaneous low frequency neural activity of the brain to reveal networks of correlated neural activity. A number of different methodologies, each with its own advantages and disadvantages, have been used to examine networks of neural activity that may be related to clinical presentation. Major depressive disorder (MDD) research has largely focused on the default mode network (DMN), which is most active at rest and may relate to negative rumination. However, other networks can be discerned in the resting state such as salience and affective and cognitive control networks, all of which may be relevant to MDD psychopathology. This article reviews the rapidly increasing literature on resting state networks. A number of state- and trait-dependent abnormalities have been reported in MDD in a wide variety of regions including the cerebellum, lingual gyrus, anterior cingulate cortex (ACC), middle frontal gyrus (MFG), dorsolateral prefrontal cortex (dlPFC), amygdala and insula. Current and chronic medication is often a potential confound. Few trials have examined the immediate or delayed effects of antidepressants on resting state networks. This article presents a novel approach to the analysis of drug effects, the identification of signatures of efficacy, and thus for drug development.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Default mode network; Functional magnetic resonance imaging; Major depressive disorder; Resting state; Salience network

Mesh:

Year:  2014        PMID: 25456520     DOI: 10.1016/j.pscychresns.2014.10.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  80 in total

1.  Differential functional brain network connectivity during visceral interoception as revealed by independent component analysis of fMRI TIME-series.

Authors:  Behnaz Jarrahi; Dante Mantini; Joshua Henk Balsters; Lars Michels; Thomas M Kessler; Ulrich Mehnert; Spyros S Kollias
Journal:  Hum Brain Mapp       Date:  2015-08-07       Impact factor: 5.038

Review 2.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

3.  Resting-state neural signatures of depressive symptoms in acute HIV.

Authors:  Carissa L Philippi; Leah Reyna; Laura Nedderman; Phillip Chan; Vishal Samboju; Kevin Chang; Nittaya Phanuphak; Nisakorn Ratnaratorn; Joanna Hellmuth; Khunthalee Benjapornpong; Netsiri Dumrongpisutikul; Mantana Pothisri; Merlin L Robb; Jintanat Ananworanich; Serena Spudich; Victor Valcour; Robert Paul
Journal:  J Neurovirol       Date:  2020-01-27       Impact factor: 2.643

4.  Adult neuroplasticity: A new “cure” for major depression?

Authors:  Paul R. Albert
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

5.  Co-Variation of Peripheral Levels of miR-1202 and Brain Activity and Connectivity During Antidepressant Treatment.

Authors:  Juan Pablo Lopez; Fabricio Pereira; Stéphane Richard-Devantoy; Marcelo Berlim; Eduardo Chachamovich; Laura M Fiori; Paola Niola; Gustavo Turecki; Fabrice Jollant
Journal:  Neuropsychopharmacology       Date:  2017-01-12       Impact factor: 7.853

6.  Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder.

Authors:  Allison C Nugent; Stephen E Robinson; Richard Coppola; Maura L Furey; Carlos A Zarate
Journal:  Neuroimage       Date:  2015-05-30       Impact factor: 6.556

7.  White matter abnormalities predict residual negative self-referential thinking following treatment of late-life depression with escitalopram: A preliminary study.

Authors:  Lindsay W Victoria; George S Alexopoulos; Irena Ilieva; Aliza T Stein; Matthew J Hoptman; Naib Chowdhury; Matteo Respino; Sarah Shizuko Morimoto; Dora Kanellopoulos; Jimmy N Avari; Faith M Gunning
Journal:  J Affect Disord       Date:  2018-09-11       Impact factor: 4.839

8.  Neural markers of depression risk predict the onset of depression.

Authors:  Benjamin G Shapero; Xiaoqian J Chai; Mark Vangel; Joseph Biederman; Christian S Hoover; Susan Whitfield-Gabrieli; John D E Gabrieli; Dina R Hirshfeld-Becker
Journal:  Psychiatry Res Neuroimaging       Date:  2019-01-25       Impact factor: 2.376

9.  Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations.

Authors:  Sirio Cocozza; Giuseppe Pontillo; Mario Quarantelli; Francesco Saccà; Eleonora Riccio; Teresa Costabile; Gaia Olivo; Vincenzo Brescia Morra; Antonio Pisani; Arturo Brunetti; Enrico Tedeschi
Journal:  Hum Brain Mapp       Date:  2018-01-09       Impact factor: 5.038

Review 10.  Pharmacological MRI (phMRI) of the Human Central Nervous System.

Authors:  H Lanfermann; C Schindler; J Jordan; N Krug; P Raab
Journal:  Clin Neuroradiol       Date:  2015-09-02       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.